Truist Securities Maintains Buy on Microsoft, Maintains $600 Price Target
Wedbush Analyst Dan Ives Raises Microsoft's Price Target To $550: 'Tidal Wave Of Copilot And Azure Monetization Now On The Doorstep' For Redmond
RBC Capital Maintains Outperform on Amgen, Raises Price Target to $332
Amgen Analyst Ratings
President Capital Adjusts Price Target on Visa to $300 From $293
Tigress Financial Adjusts Price Target on Microsoft to $550 From $475, Keeps Buy Rating
Tigress Financial raised microsoft's target price to $550.
Microsoft Analyst Ratings
Tigress Financial Maintains Buy on Microsoft, Raises Price Target to $550
Wolfe Research Adjusts Price Target on UnitedHealth Group to $589 From $536, Keeps Outperform Rating
Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group, Maintains $591 Price Target
UnitedHealth Group Analyst Ratings
Cathie Wood, Ark Invest Set New $2,600 Price Target For Tesla: 'Every Car Becomes An AI-Powered Cash Flow Generation Machine'
Research Alert: CFRA Adds Amgen Inc. To The High-quality Capital Appreciation Portfolio
Raymond James Financial raised the target price of Microsoft to $480.
Microsoft Analyst Ratings
Microsoft Analyst Ratings
Oppenheimer Adjusts Price Target on Microsoft to $500 From $450
Itau BBA Raises Price Target on Microsoft to $460 From $436
Bank Rating | Bocom Intl: AI theme in the technology industry in the second half of the year may continue, and semiconductors may continue to differentiate.